Cargando…

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma

Mostrar otras versiones (1)

Colorectal cancer (CRC) is one of top five leading causes of cancer-associated mortalities worldwide. 5-Fluorouracil (5-FU) is the first-line chemotherapeutic drug in the treatment of CRC; however, its antineoplastic efficiency is limited due to acquired drug resistance. The regulatory mechanism und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Xia, Mingyue, Zhang, Ziyu, Tan, Yanyin, Li, Enjie, Guo, Zhigang, Fang, Mingzhi, Zhu, Yong, Hu, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374465/ https://www.ncbi.nlm.nih.gov/pubmed/35856434 http://dx.doi.org/10.3892/ijo.2022.5396

Ejemplares similares

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2023)

METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis
por: Li, Enjie, et al.
Publicado: (2022)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
por: Zhang, Y, et al.
Publicado: (2015)

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
por: Zhang, Y, et al.
Publicado: (2016)

ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
por: Xu, Rongzhong, et al.
Publicado: (2017)

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2022)

Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2023)

METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility
por: Ge, Lili, et al.
Publicado: (2022)

Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
por: Long, Kaili, et al.
Publicado: (2021)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

Expression and clinical significance of METTL3 in colorectal cancer
por: Li, Hui, et al.
Publicado: (2023)

A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients
por: Chen, Qi, et al.
Publicado: (2017)

ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction
por: Long, Sirui, et al.
Publicado: (2022)

METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: An Eight-Center Case-Control Study
por: Zhuo, Zhenjian, et al.
Publicado: (2020)

miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1
por: Yin, Jie, et al.
Publicado: (2018)

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells
por: Rauch, Anke, et al.
Publicado: (2018)

Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
por: Ishida, Kazushige, et al.
Publicado: (2012)

Angelica Polysaccharide Antagonizes 5-FU-Induced Oxidative Stress Injury to Reduce Apoptosis in the Liver Through Nrf2 Pathway
por: Zeng, Di, et al.
Publicado: (2021)

METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis
por: Zhang, Guoying, et al.
Publicado: (2022)

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy
por: Webber, Elizabeth M, et al.
Publicado: (2015)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway
por: Ji, Feng, et al.
Publicado: (2021)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
por: Li, Sheng, et al.
Publicado: (2014)

The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials
por: Xia, Mingyue, et al.
Publicado: (2021)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
por: Helderman, Roxan F.C.P.A., et al.
Publicado: (2020)

Ultrasensitive response explains the benefit of combination chemotherapy despite drug antagonism
por: Patterson, Sarah C., et al.
Publicado: (2023)

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
por: Zhu, Yiping, et al.
Publicado: (2020)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Up-regulation of FAT4 enhances the chemosensitivity of colorectal cancer cells treated by 5-FU
por: Li, Qianyuan, et al.
Publicado: (2020)

DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance
por: Xie, Pan, et al.
Publicado: (2021)

Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer
por: Li, Qing-Fang, et al.
Publicado: (2010)

CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis
por: Zhu, Mingzhi, et al.
Publicado: (2021)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

Correction: Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i0pfebiaknd8giqjpaddro960j